NCT02263469View on ClinicalTrials.gov

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2006

Conditions
Haemophilia B
Interventions
BIOLOGICAL

Replenine®-VF (High Purity Factor IX)

Trial Locations (4)

79044

Institute of Blood Pathology and Transfusion Medicine, Academy of Medical Science of Ukraine, Gen. Chuprynkea Str., Lviv

83045

Institute of Urgent and Recovery Surgery, Academy of Medical Science of Ukraine, Leninski Avenue, Donetsk

Unknown

Samodzielny Publiczny Dzieciecy Szpital Kliniczny, Oddzial Pediatrii, Hematologii I Onkologii, ul. Marszalkowska 24, 00-576, Warsaw

Institute of Haematology and Transfusiology, Academy of Medical Science of Ukrainem Berlynskogo Str., Kiev

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER